comparemela.com

Latest Breaking News On - Department of immuntechnology at lund university - Page 1 : comparemela.com

Immunovia appoints Philipp Mathieu as Acting CEO

/PRNewswire/ Immunovia AB (publ) announces that Philipp Mathieu has been appointed acting CEO and President with immediate effect. The search for a.

Sweden
United-states
Stockholm
Massachusetts
Carl-borrebaeck
Philipp-mathieu
Immunovia-inc
Corporate-communications
Department-of-immuntechnology-at-lund-university
Health-cancer-center
Director-investor-relations
Lund-university

Immunovia AB: Immunovia appoints Philipp Mathieu as Acting CEO

LUND, Sweden, Jan. 20, 2022 /PRNewswire/ Immunovia AB (publ) announces that Philipp Mathieu has been appointed acting CEO and President with immediate effect. The search for a permanent CEO

Sweden
United-states
Stockholm
Massachusetts
Carl-borrebaeck
Immray-pancan-d
Philipp-mathieu
Immunovia-inc
Corporate-communications
Department-of-immuntechnology-at-lund-university
Health-cancer-center
Director-investor-relations

Immunovia's CEO to step down during 2022

/PRNewswire/ Immunovia AB (publ.) announced today that the Company s President and Chief Executive Officer, Patrik Dahlen, has informed the Board of.

Sweden
United-states
Stockholm
Massachusetts
Carl-borrebaeck
Patrik-dahlen
Immunovia-inc
Department-of-immuntechnology-at-lund-university
Health-cancer-center
Chief-executive-officer
Lund-university
Cancer-center

Immunovia AB: Immunovia's CEO to step down during 2022

LUND, Sweden, Nov. 30, 2021 /PRNewswire/ Immunovia AB (publ.) announced today that the Company's President and Chief Executive Officer, Patrik Dahlen, has informed the Board of Directors

Sweden
United-states
Stockholm
Massachusetts
Carl-borrebaeck
Immray-pancan-d
Patrik-dahlen
Immunovia-inc
Department-of-immuntechnology-at-lund-university
Health-cancer-center
Chief-executive-officer
Lund-university

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.